You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
回購+南下資金增持 三生製藥(1530.HK)快速反彈漲5%
格隆匯 03-02 15:13
格隆匯3月2日丨近日持續下跌的三生製藥(1530.HK)今早一度創3年新低,隨後快速反彈,目前漲4.95%報8.48港元,暫成交2.56億港元,最新總市值215億港元。格隆匯平台今早發佈文章《三生製藥(1530.HK):股價跳水,是資金恐慌出逃還是意外錯殺?》指出,對於股價近日的下跌,富瑞的研報是導火線,但從研報內容來看,擔心高管變動恐怕有所誤解,公司的經營能力仍舊十分強勁。核心產品益賽普已經拿下了菲律賓市場,臨牀審批也在逐步推進,公司現金流也很穩定,並且還在參與腫瘤領域的基金投資佈局,分拆上市科創版的三生國健也在順利推進。對於此次下跌,公司已經採取股票回購方式增強股東權益,而南下資金也看到了錯殺中的機會,近5日的資金流動一直處於流入狀態。從估值角度而言,PE/PB已經處於歷史低位。查看詳情可點擊下列鏈接。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account